Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

European Innovation Council · Finished

METAflow Development and validation of the first digital, clinical grade flow cytometry platform for enhanced diagnosis accuracy and sustainability in immunology and hemato oncology

Coordinator
Metafora Biosystems, France
Runs
1 January 2023 to 30 June 2024
Status
Finished
EU funding
€2.5m
Total cost
€3.6m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190166506

What the project is doing

In the project's own words, from its summary on CORDIS.

After successful development of METAglut1, an IVD Medical Device for diagnosis of the Glut1 Deficiency Syndrome ( available for clinical use), we are currently focused on developing a new breakthrough solution: METAflow. Flow cytometry (FC) is a powerful tool widely use in research. However, the high cost and complexity of interpretation of FC data hampers its full clinical exploitation. Main pain-points of clinical FC data analysis, include need for manual analysis, which is accompanied by complexity with increasing number of dimensions, lack of robustness and limited scale-up.

The lack of automated analytical process stems from dearth of robust algorithms, limited regulatory compliance and need for considerable coding skills. With METAflow we bring to the market the first digital, clinical grade FC platform, which offers comprehensive data analysis, robustness, and usability, addressing the lost in translational research issue of flow cytometry in the clinics.

Topics

Who is involved

OrganisationCityCountryRole
Metafora BiosystemsParisFranceCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI